Full Product Details
Author: Steven C. Schachter (Harvard Medical School) ,
Wade E. Bolton (VentureWell/Rapid Acceleration of Diagnostics (RADx))
Publisher: Cambridge University Press
Imprint: Cambridge University Press
Dimensions:
Width: 15.60cm
, Height: 1.60cm
, Length: 23.40cm
Weight: 0.515kg
ISBN: 9781009396981
ISBN 10: 1009396986
Pages: 300
Publication Date: 07 March 2024
Audience:
General/trade
,
General
Format: Paperback
Publisher's Status: Active
Availability: Manufactured on demand
We will order this item for you from a manufactured on demand supplier.
Reviews
'I need to know what to do to protect people, my family, and my co-workers. I'm interested in all the areas this book covers.' Mirna DiPano, Ph.D., Vice President Regulatory and Clinical Affairs at NanoString Technologies, Inc. 'The concept addresses the significant gap that exists in the timely development of diagnostics that are both reliable and fit for purpose, a subject I am very interested in. I am very heartened that you have taken a multi-disciplinary approach to build a roadmap for the next pandemic and am curious to learn more.' Susie Braniff, Ph.D., Scientist, WHO, In Vitro Diagnostic Assessment Team 'OMG, this is going to be a landmark book. I cannot wait to read it.' Marcelle Abell-Rosen, M.D., Internal Medicine Physician 'An outstanding blend of science, real-world insights, and practical guidance that will be of great interest for both the lay audience and scientists. The diverse voices and visual roadmaps make this book a comprehensive and actionable guide, leaving readers better equipped to face future pandemics.' David A. Hafler, M.D., William S. and Lois Stiles Edgerly Professor of Neurology and Professor of Immunobiology,Chairman, Department of Neurology Yale School of Medicine; Neurologist-in-Chief Yale New Haven Hospital 'This book essentially reverse-engineers and then lays out the pathway that we were all involved in but we all failed to prepare for. This is a detailed, essential guide that provides a well-documented process for the managing our next pandemic.' J. Paul Robinson, Distinguished Professor of Cytometry, Professor of Biomedical Engineering, Professor of Computer and Information Management at Purdue University; Adjunct Professor of Microbiology & Immunology at West Lafayette Center for Medical Education, Indiana University School of Medicine; Director of Purdue University Cytometry Laboratories 'Future generations are certain to face public health challenges. Those of us who lived and worked through the COVID-19 pandemic have a duty to document and provide a roadmap to those who follow us and may need to urgently respond to similar challenges. The book, Accelerating Diagnostics in a Time of Crisis: The Response to COVID-19 and a Roadmap to Future Pandemics is an excellent resource for policymakers and those who are part of global public health responses.' Thomas N. Denny, M.Sc, M.Phil., Professor of Medicine, Chief Operating Officer, Duke Human Vaccine Institute; Director, Immunology and Virology Quality Assessment Center; Associate Dean for Duke Research and Discovery @ RTP 'After the COVID-19 crisis, the editors and contributors have put together a timely and pertinent publication that tackles the persistent issue of lessons learnt to prepare for future pandemics. This comprehensive work covers a range of crucial subjects, including early detection, immunology, surveillance, diagnostics, and the societal ramifications of pandemics.' Christopher Rudd, Christopher Rudd, Ph.D., DSc, FMedSci, FCAHS, FRSC, Professeur, Faculte de Medicine, Dept de microbiologie, infectiologie et immunologie, Director- Cell Signaling and Immunotherapy Section, Universite de Montreal
Author Information
Steven Schachter, MD is a Professor of Neurology at Harvard Medical School and Chief Academic Officer for CIMIT, Boston. As RADx Chief, Dr. Schachter led the design and implementation of the extramural aspects of the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) initiative to speed innovation in the development of technologies for COVID-19 testing. Wade Bolton, Ph.D. is Team Lead and Content Expert for VentureWell and works with the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) initiative to speed innovation in the development of technologies for COVID-19 testing. Previously, he was Divisional Vice President for Hematology Research and Development at Abbott Laboratories.
